–
Liminatus Pharma, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−2.71
FY23:
−4.82
FY24:
−3.33
FY25:
−2.97
(positive)
Change from FY22 to FY25
millions USD
FY22:
−2.71
FY23:
−4.81
FY24:
−3.21
FY25:
−10.4
(positive)
Change from FY22 to FY25
millions USD
FY22:
−2.93
FY23:
−4.98
FY24:
−3.55
FY25:
−10.2
(positive)
Change from FY22 to FY25
millions USD
FY22:
−2.93
FY23:
−4.98
FY24:
−3.55
FY25:
−10.2
All amounts in millions USD FY22, FY23: figures supplemented from Twelve Data because the SEC filings do not reach back this far.